Bianco Domenico, Armstrong P Jane, Washabau Robert J
Veterinary Clinical Sciences Department, Veterinary Medical Center, College of Veterinary Medicine, University of Minnesota, 1365 Gortner Avenue, St Paul, MN 55108, USA.
J Feline Med Surg. 2008 Oct;10(5):495-500. doi: 10.1016/j.jfms.2008.01.003. Epub 2008 Mar 12.
Feline primary immune-mediated thrombocytopenia (pIMT) is a rare hematological disorder. Platelet-bound antibody assays for cats have variable specificity and sensitivity and are not widely available. Diagnosis of pIMT is made on the basis of exclusion of other identifiable causes of thrombocytopenia and the response to immunosuppressive therapy. This report describes four cats with severe thrombocytopenia and no detectable underlying disease. One cat was euthanased because of pulmonary hemorrhage, while the other cats had frequent relapses, two of these cats developed diabetes mellitus due to long-term corticosteroid therapy. In these cats IMT had a chronic course and responded poorly to therapy with prednisolone. Alternative immunomodulatory drugs may be considered in the treatment of feline IMT.
猫原发性免疫介导性血小板减少症(pIMT)是一种罕见的血液系统疾病。针对猫的血小板结合抗体检测具有不同的特异性和敏感性,且未广泛应用。pIMT的诊断基于排除其他可识别的血小板减少病因以及对免疫抑制治疗的反应。本报告描述了四只患有严重血小板减少症且未检测到潜在疾病的猫。其中一只猫因肺出血而安乐死,其他猫频繁复发,其中两只猫因长期使用皮质类固醇治疗而患上糖尿病。在这些猫中,IMT病程呈慢性,对泼尼松龙治疗反应不佳。在猫IMT的治疗中可考虑使用其他免疫调节药物。